Simulation assessments of statistical aspects of bioequivalence in the pharmaceutical industry
- 1 January 2004
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 3 (1), 13-23
- https://doi.org/10.1002/pst.88
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Bioequivalence and the pharmaceutical industryPharmaceutical Statistics, 2002
- Individual bioequivalence testing under 2×3 designsStatistics in Medicine, 2002
- Population and Individual Bioequivalence: Lessons from Real Data and Simulation StudiesThe Journal of Clinical Pharmacology, 2001
- Consistency of the bootstrap procedure in individual bioequivalenceBiometrika, 2000
- A regulatory perspective on pharmacokinetic/pharmacodynamic modellingStatistical Methods in Medical Research, 1999
- Statistical and Regulatory Considerations for Multiple Measures in Bioequivalence TestingClinical Research and Regulatory Affairs, 1995
- Consideration of individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1990
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Recovery of inter-block information when block sizes are unequalBiometrika, 1971
- Synthesis of variancePsychometrika, 1941